-
1
-
-
0033740930
-
Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997
-
Egan JF, Benn P, Borgida AF, et al. Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997. Obstet Gynecol 2000, 96:979-985.
-
(2000)
Obstet Gynecol
, vol.96
, pp. 979-985
-
-
Egan, J.F.1
Benn, P.2
Borgida, A.F.3
-
2
-
-
0002682681
-
Prevalence, risk and recurrence
-
Churchill Livingstone, Edinburgh, D.H. Brock, C.H. Rodeck, M.A. Ferguson-Smith (Eds.)
-
Hook EB Prevalence, risk and recurrence. Prenatal Diagnosis and Screening 1992, 351-392. Churchill Livingstone, Edinburgh. D.H. Brock, C.H. Rodeck, M.A. Ferguson-Smith (Eds.).
-
(1992)
Prenatal Diagnosis and Screening
, pp. 351-392
-
-
Hook, E.B.1
-
3
-
-
0028849426
-
Maternal age and gestational age specific risks for chromosomal defects
-
Snijders RJM, Sebire NJ, Nicolaides KH Maternal age and gestational age specific risks for chromosomal defects. Fetal Diag Ther 1995, 10:356-357.
-
(1995)
Fetal Diag Ther
, vol.10
, pp. 356-357
-
-
Snijders, R.J.M.1
Sebire, N.J.2
Nicolaides, K.H.3
-
5
-
-
0000922691
-
Observations on an ethnic classification of idiots
-
Down J.L. Observations on an ethnic classification of idiots. Lond Hosp Rep 1866, 3:259-262.
-
(1866)
Lond Hosp Rep
, vol.3
, pp. 259-262
-
-
Down, J.L.1
-
6
-
-
0001105689
-
Mongoloid imbecility
-
Shuttleworth GE Mongoloid imbecility. Br Med J 1909, 2:661-665.
-
(1909)
Br Med J
, vol.2
, pp. 661-665
-
-
Shuttleworth, G.E.1
-
7
-
-
70449245071
-
Etudes des chromosomes somatiques de neuf enfants mongoliens
-
Lejeune J, Gautier M, Turpin R. Etudes des chromosomes somatiques de neuf enfants mongoliens. C R Acad Sci 1959, 248:1721.
-
(1959)
C R Acad Sci
, vol.248
, pp. 1721
-
-
Lejeune, J.1
Gautier, M.2
Turpin, R.3
-
10
-
-
50549169392
-
Multiple congenital anomaly caused by an extra auto-some
-
Patau K, Smith DW, Therman E, et al. Multiple congenital anomaly caused by an extra auto-some. Lancet 1960, 1:790-793.
-
(1960)
Lancet
, vol.1
, pp. 790-793
-
-
Patau, K.1
Smith, D.W.2
Therman, E.3
-
11
-
-
0007807354
-
Recommendations arising from the 32nd Study Group: screening for down syndrome in the first trimester
-
Royal College of Obstetricians and Gynaecologists, RCOG Press, London, J.G. Grudzinskas, R.H.T. Ward (Eds.)
-
Royal College of Obstetricians and Gynaecologists Recommendations arising from the 32nd Study Group: screening for down syndrome in the first trimester. Screening for Down Syndrome in the First Trimester 1997, 353-356. RCOG Press, London. J.G. Grudzinskas, R.H.T. Ward (Eds.).
-
(1997)
Screening for Down Syndrome in the First Trimester
, pp. 353-356
-
-
-
12
-
-
0032999749
-
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A
-
Spencer K, Souter V, Tul N, et al. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999, 13:231-237.
-
(1999)
Ultrasound Obstet Gynecol
, vol.13
, pp. 231-237
-
-
Spencer, K.1
Souter, V.2
Tul, N.3
-
13
-
-
0036179264
-
Point of care screening for chromosomal anomalies in the first trimester
-
Spencer K. Point of care screening for chromosomal anomalies in the first trimester. Clin Chem 2002, 48:403-404.
-
(2002)
Clin Chem
, vol.48
, pp. 403-404
-
-
Spencer, K.1
-
14
-
-
0037333249
-
Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years prospective experience
-
Spencer K, Spencer CE, Power M, et al. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years prospective experience. Br J Obstet Gynaecol 2003, 110:281-286.
-
(2003)
Br J Obstet Gynaecol
, vol.110
, pp. 281-286
-
-
Spencer, K.1
Spencer, C.E.2
Power, M.3
-
15
-
-
33947192131
-
Screening at the point of care: Down syndrome-a case study
-
AACC Press, Washington, C.P. Price, A. St John, J.M. Hicks (Eds.)
-
Spencer K. Screening at the point of care: Down syndrome-a case study. Point of Care Testing. 2004, 333-339. AACC Press, Washington. C.P. Price, A. St John, J.M. Hicks (Eds.).
-
(2004)
Point of Care Testing.
, pp. 333-339
-
-
Spencer, K.1
-
16
-
-
0032710295
-
Screening for trisomy 18 by fetal nuchal translucency, maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation
-
Tul N, Spencer K, Noble P, et al. Screening for trisomy 18 by fetal nuchal translucency, maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 1999, 19:1035-1042.
-
(1999)
Prenat Diagn
, vol.19
, pp. 1035-1042
-
-
Tul, N.1
Spencer, K.2
Noble, P.3
-
17
-
-
0034073499
-
Screening for trisomy 13 by fetal nuchal translucency thickness and maternal serum free β-hCG and PAPP-A at 10-14 weeks
-
Spencer K, Ong C, Skentou H, et al. Screening for trisomy 13 by fetal nuchal translucency thickness and maternal serum free β-hCG and PAPP-A at 10-14 weeks. Prenat Diagn 2000, 20:411-416.
-
(2000)
Prenat Diagn
, vol.20
, pp. 411-416
-
-
Spencer, K.1
Ong, C.2
Skentou, H.3
-
18
-
-
0036796080
-
A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free β-hCG and PAPP-A
-
Spencer K, Nicolaides KH A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free β-hCG and PAPP-A. Prenat Diagn 2002, 22:877-879.
-
(2002)
Prenat Diagn
, vol.22
, pp. 877-879
-
-
Spencer, K.1
Nicolaides, K.H.2
-
19
-
-
0034108953
-
Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy
-
Spencer K, Berry E, Crossley JA, et al. Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy. Prenat Diagn 2000, 20:311-317.
-
(2000)
Prenat Diagn
, vol.20
, pp. 311-317
-
-
Spencer, K.1
Berry, E.2
Crossley, J.A.3
-
20
-
-
0025011297
-
The mathematical basis of multivariate risk analysis: with special reference to screening for Down syndrome associated pregnancy
-
Reynolds T, Penney M. The mathematical basis of multivariate risk analysis: with special reference to screening for Down syndrome associated pregnancy. Ann Clin Biochem 1990, 27:452-458.
-
(1990)
Ann Clin Biochem
, vol.27
, pp. 452-458
-
-
Reynolds, T.1
Penney, M.2
-
21
-
-
0001179668
-
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation
-
Snijders RJM, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1999, 18:519-521.
-
(1999)
Lancet
, vol.18
, pp. 519-521
-
-
Snijders, R.J.M.1
Noble, P.2
Sebire, N.3
-
22
-
-
0029588613
-
Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation
-
Pandya PP, Snijders RJM, Johnson SP, et al. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 1995, 102:957-962.
-
(1995)
Br J Obstet Gynaecol
, vol.102
, pp. 957-962
-
-
Pandya, P.P.1
Snijders, R.J.M.2
Johnson, S.P.3
-
23
-
-
0037541122
-
Screening for chromosomal defects
-
Nicolaides KH Screening for chromosomal defects. Ultrasound Obstet Gynecol 2003, 21:313-321.
-
(2003)
Ultrasound Obstet Gynecol
, vol.21
, pp. 313-321
-
-
Nicolaides, K.H.1
-
24
-
-
84882497237
-
-
National Institute for Clinical Excellence Antenatal care: routine care for the healthy pregnant woman. Clinical Guidance No. 6, 2003. healthy pregnant woman. Clinical Guidance No. 6.
-
(2003)
-
-
-
25
-
-
84882503727
-
National Down's Syndrome Screening Programme for England.
-
National Down's Syndrome Screening Programme for England. Antenatal Screening-Working Standards 2004.
-
Antenatal Screening-Working Standards 2004.
-
-
-
26
-
-
16244402632
-
Committee Opinion No. 296. First trimester screening for fetal aneuploidy
-
ACOG
-
ACOG Committee Opinion No. 296. First trimester screening for fetal aneuploidy. Obstet Gynecol 2004, 104:215-217.
-
(2004)
Obstet Gynecol
, vol.104
, pp. 215-217
-
-
-
27
-
-
0141613852
-
Rapid and simple antenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods of FISH and QF-PCR
-
Hulten MA, Dhanjal S, Pertl B. Rapid and simple antenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods of FISH and QF-PCR. Reproduction 2003, 126:279-297.
-
(2003)
Reproduction
, vol.126
, pp. 279-297
-
-
Hulten, M.A.1
Dhanjal, S.2
Pertl, B.3
-
28
-
-
0036378243
-
One stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies
-
Bindra R, Heath V, Liao A, et al. One stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies. Ultrasound Obstet Gynecol 2002, 20:219-225.
-
(2002)
Ultrasound Obstet Gynecol
, vol.20
, pp. 219-225
-
-
Bindra, R.1
Heath, V.2
Liao, A.3
-
29
-
-
0027447232
-
Age-specific detection and false positive rates: an aid to counseling in Down's Syndrome risk screening
-
Reynolds TM, Nix AB, Dunstan FD, et al. Age-specific detection and false positive rates: an aid to counseling in Down's Syndrome risk screening. Obstet Gynecol 1993, 81:447-450.
-
(1993)
Obstet Gynecol
, vol.81
, pp. 447-450
-
-
Reynolds, T.M.1
Nix, A.B.2
Dunstan, F.D.3
-
30
-
-
0034792982
-
Age related detection and false positive rates when screening for Down's Syndrome in the first trimester using fetal nuchal translucency and maternal serum free a-hCG and PAPP-A
-
Spencer K. Age related detection and false positive rates when screening for Down's Syndrome in the first trimester using fetal nuchal translucency and maternal serum free a-hCG and PAPP-A. Br J Obstet Gynaecol 2001, 108:1043-1046.
-
(2001)
Br J Obstet Gynaecol
, vol.108
, pp. 1043-1046
-
-
Spencer, K.1
-
31
-
-
0034062921
-
Maternal serum free β-hCG and PAPP-A in fetal sex chromosome defects in the first trimester
-
Spencer K, Tul N, Nicolaides KH Maternal serum free β-hCG and PAPP-A in fetal sex chromosome defects in the first trimester. Prenat Diagn 2000, 20:390-394.
-
(2000)
Prenat Diagn
, vol.20
, pp. 390-394
-
-
Spencer, K.1
Tul, N.2
Nicolaides, K.H.3
-
32
-
-
0034041082
-
Screening for triploidy by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation
-
Spencer K, Liao AWJ, Skentou H, et al. Screening for triploidy by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 2000, 20:852-853.
-
(2000)
Prenat Diagn
, vol.20
, pp. 852-853
-
-
Spencer, K.1
Liao, A.W.J.2
Skentou, H.3
-
33
-
-
0037333795
-
Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years experience
-
Spencer K, Nicolaides KH Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years experience. Br J Obstet Gynaecol 2003, 110:276-280.
-
(2003)
Br J Obstet Gynaecol
, vol.110
, pp. 276-280
-
-
Spencer, K.1
Nicolaides, K.H.2
-
35
-
-
0035685960
-
Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype
-
Ghi T, Huggon IC, Zosmer N, et al. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001, 18:610-614.
-
(2001)
Ultrasound Obstet Gynecol
, vol.18
, pp. 610-614
-
-
Ghi, T.1
Huggon, I.C.2
Zosmer, N.3
-
36
-
-
0035080229
-
Limitations of using first trimester nuchal translucency measurement in routine screening for major congenital heart defects
-
Mavrides E, Cobian-Sanchez F, Tekay A, et al. Limitations of using first trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001, 17:106-110.
-
(2001)
Ultrasound Obstet Gynecol
, vol.17
, pp. 106-110
-
-
Mavrides, E.1
Cobian-Sanchez, F.2
Tekay, A.3
-
37
-
-
0034920539
-
Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester
-
Souka AP, Krampl E, Bakalis S, et al. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001, 18:9-17.
-
(2001)
Ultrasound Obstet Gynecol
, vol.18
, pp. 9-17
-
-
Souka, A.P.1
Krampl, E.2
Bakalis, S.3
-
38
-
-
0033799683
-
First trimester maternal serum a-human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications
-
Ong CYT, Liao AW, Spencer K, et al. First trimester maternal serum a-human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. Br J Obstet Gynaecol 2000, 107:1265-1270.
-
(2000)
Br J Obstet Gynaecol
, vol.107
, pp. 1265-1270
-
-
Ong, C.Y.T.1
Liao, A.W.2
Spencer, K.3
-
39
-
-
0036281056
-
Early pregnancy levels of pregnancy associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth
-
Smith GCS, Stenhouse EJ, Crossley JA, et al. Early pregnancy levels of pregnancy associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002, 87:1762-1767.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 1762-1767
-
-
Smith, G.C.S.1
Stenhouse, E.J.2
Crossley, J.A.3
-
41
-
-
0036733227
-
Decreased first trimester PAPP-A is a predictor of adverse outcome
-
Yaron Y, Heifetz S, Ochshorn Y, et al. Decreased first trimester PAPP-A is a predictor of adverse outcome. Prenat Diagn 2002, 22:778-782.
-
(2002)
Prenat Diagn
, vol.22
, pp. 778-782
-
-
Yaron, Y.1
Heifetz, S.2
Ochshorn, Y.3
-
42
-
-
0347478051
-
Predicting complications of pregnancy with first trimester maternal serum free β-hCG, PAPP-A and inhibin-A
-
Tul N, Pusenjak S, Osredkar J, et al. Predicting complications of pregnancy with first trimester maternal serum free β-hCG, PAPP-A and inhibin-A. Prenat Diagn 2003, 23:990-996.
-
(2003)
Prenat Diagn
, vol.23
, pp. 990-996
-
-
Tul, N.1
Pusenjak, S.2
Osredkar, J.3
-
43
-
-
0033899471
-
Second trimester antenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complication with adverse outcome
-
Spencer K. Second trimester antenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complication with adverse outcome. Prenat Diagn 2000, 20:652-656.
-
(2000)
Prenat Diagn
, vol.20
, pp. 652-656
-
-
Spencer, K.1
-
45
-
-
0030048402
-
Justifying prenatal screening and genetic amniocentesis programs by cost-effectiveness analyses: a re-evaluation
-
Ganiats TG Justifying prenatal screening and genetic amniocentesis programs by cost-effectiveness analyses: a re-evaluation. Med Decis Making 1996, 16:45-50.
-
(1996)
Med Decis Making
, vol.16
, pp. 45-50
-
-
Ganiats, T.G.1
-
46
-
-
0033858982
-
Recent economic evaluations of antenatal screening: a systematic review and critique
-
Petrou S, Henderson J, Roberts T, et al. Recent economic evaluations of antenatal screening: a systematic review and critique. J Med Screen 2000, 7:59-73.
-
(2000)
J Med Screen
, vol.7
, pp. 59-73
-
-
Petrou, S.1
Henderson, J.2
Roberts, T.3
-
47
-
-
0034052693
-
Cost-benefit analysis of prenatal diagnosis for Down syndrome using the British or the American approach
-
Vintzileos AM, Ananth CV, Smulian JC, et al. Cost-benefit analysis of prenatal diagnosis for Down syndrome using the British or the American approach. Obstet Gynecol 2000, 95:577-583.
-
(2000)
Obstet Gynecol
, vol.95
, pp. 577-583
-
-
Vintzileos, A.M.1
Ananth, C.V.2
Smulian, J.C.3
-
48
-
-
0035949076
-
Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies
-
Gilbert RE, Augood C, Gupta R, et al. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ 2001, 323:423-425.
-
(2001)
BMJ
, vol.323
, pp. 423-425
-
-
Gilbert, R.E.1
Augood, C.2
Gupta, R.3
-
49
-
-
0036856194
-
Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis
-
Caughey AB, Kuppermann M, Norton ME, et al. Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis. Am J Obstet Gynecol 2002, 187:1239-1245.
-
(2002)
Am J Obstet Gynecol
, vol.187
, pp. 1239-1245
-
-
Caughey, A.B.1
Kuppermann, M.2
Norton, M.E.3
-
50
-
-
0036291453
-
An increase in cost effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing
-
Christiansen M, Olesen Larsen S. An increase in cost effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing. Prenat Diagn 2002, 22:482-486.
-
(2002)
Prenat Diagn
, vol.22
, pp. 482-486
-
-
Christiansen, M.1
Olesen Larsen, S.2
-
51
-
-
0037341233
-
Combined first trimester versus second trimester serum screening for Down syndrome: a cost analysis
-
Cusick W, Buchanan P, Hallahan TW, Krantz DA, Larsen JW, Macri JN Combined first trimester versus second trimester serum screening for Down syndrome: a cost analysis. Am J Obstet Gynecol 2003, 188:745-751.
-
(2003)
Am J Obstet Gynecol
, vol.188
, pp. 745-751
-
-
Cusick, W.1
Buchanan, P.2
Hallahan, T.W.3
Krantz, D.A.4
Larsen, J.W.5
Macri, J.N.6
-
52
-
-
85045797401
-
First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)
-
Wald NJ, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003, 7:11.
-
(2003)
Health Technol Assess
, vol.7
, pp. 11
-
-
Wald, N.J.1
Rodeck, C.2
Hackshaw, A.K.3
-
53
-
-
0027320802
-
An economic appraisal of alternative pre-natal screening programmes fro Down's syndrome
-
Shackley P, McGuire A, Boyd PA, et al. An economic appraisal of alternative pre-natal screening programmes fro Down's syndrome. J Public Health Med 1993, 15:175-184.
-
(1993)
J Public Health Med
, vol.15
, pp. 175-184
-
-
Shackley, P.1
McGuire, A.2
Boyd, P.A.3
-
54
-
-
0023186030
-
An economic appraisal of screening for Down's Syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration
-
Gill M, Murday V, Slack J. An economic appraisal of screening for Down's Syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration. Soc Sci Med 1987, 24:725-731.
-
(1987)
Soc Sci Med
, vol.24
, pp. 725-731
-
-
Gill, M.1
Murday, V.2
Slack, J.3
-
56
-
-
0029650542
-
Economic costs of birth defects and cerebral palsy-United States, 1992
-
Waitzman N, Romano P, Scheffler R, et al. Economic costs of birth defects and cerebral palsy-United States, 1992. MMWR Recomm Rep 1995, 44:694-699.
-
(1995)
MMWR Recomm Rep
, vol.44
, pp. 694-699
-
-
Waitzman, N.1
Romano, P.2
Scheffler, R.3
-
57
-
-
0032406152
-
Economic evaluation of prenatal screening for Down syndrome in the USA
-
Beazoglou T, Heffley D, Kyriopoulos J, et al. Economic evaluation of prenatal screening for Down syndrome in the USA. Prenat Diagn 1998, 18:1241-1252.
-
(1998)
Prenat Diagn
, vol.18
, pp. 1241-1252
-
-
Beazoglou, T.1
Heffley, D.2
Kyriopoulos, J.3
-
58
-
-
0033157130
-
Cost and effectiveness of the California triple maker prenatal screening program
-
Cunningham GC, Tompkinson DG Cost and effectiveness of the California triple maker prenatal screening program. Genet Med 1999, 1:199-206.
-
(1999)
Genet Med
, vol.1
, pp. 199-206
-
-
Cunningham, G.C.1
Tompkinson, D.G.2
-
59
-
-
1642423677
-
An outcome analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years
-
Biggio JR, Morris C, Owen J, et al. An outcome analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years. Am J Obstet Gynecol 2004, 190:721-729.
-
(2004)
Am J Obstet Gynecol
, vol.190
, pp. 721-729
-
-
Biggio, J.R.1
Morris, C.2
Owen, J.3
-
60
-
-
0036417261
-
British National Health Service's and women's costs of antenatal ultrasound screening and follow-up tests
-
Henderson J, Bricker L, Roberts T, et al. British National Health Service's and women's costs of antenatal ultrasound screening and follow-up tests. Ultrasound Obstet Gynaecol 2002, 20:154-162.
-
(2002)
Ultrasound Obstet Gynaecol
, vol.20
, pp. 154-162
-
-
Henderson, J.1
Bricker, L.2
Roberts, T.3
-
61
-
-
0007807354
-
RCOG Recommendations arising from the 32nd Study Group: screening for Down syndrome in the first trimester
-
RCOG Press, London, J.G. Grudzinskas, R.H.T. Ward (Eds.)
-
RCOG Recommendations arising from the 32nd Study Group: screening for Down syndrome in the first trimester. Screening for Down syndrome in the first trimester. 1997, 353-356. RCOG Press, London. J.G. Grudzinskas, R.H.T. Ward (Eds.).
-
(1997)
Screening for Down syndrome in the first trimester.
, pp. 353-356
-
-
-
62
-
-
0028113312
-
Abortion mortality, United States, 1972-1987
-
Lawson HW, Frye A, Atrash HK, et al. Abortion mortality, United States, 1972-1987. Am J Obstet Gynecol 1994, 171:1365-1372.
-
(1994)
Am J Obstet Gynecol
, vol.171
, pp. 1365-1372
-
-
Lawson, H.W.1
Frye, A.2
Atrash, H.K.3
-
63
-
-
0030693283
-
Women's opinions and the implications of first-versus second trimester screening for fetal Down's syndrome
-
Kornman LH, Wortelboer MJM, Beekhuis JR, et al. Women's opinions and the implications of first-versus second trimester screening for fetal Down's syndrome. Prenat Diagn 1997, 17:1011-1018.
-
(1997)
Prenat Diagn
, vol.17
, pp. 1011-1018
-
-
Kornman, L.H.1
Wortelboer, M.J.M.2
Beekhuis, J.R.3
-
64
-
-
0033795010
-
Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome
-
Mulvey S, Wallace EM Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome. Br J Obstet Gynaecol 2000, 107:1302-1305.
-
(2000)
Br J Obstet Gynaecol
, vol.107
, pp. 1302-1305
-
-
Mulvey, S.1
Wallace, E.M.2
-
65
-
-
0032517577
-
Antenatal screening for Down's syndrome
-
Monni G, Ibba RM, Zoppi MA Antenatal screening for Down's syndrome. Lancet 1998, 352:1631-1632.
-
(1998)
Lancet
, vol.352
, pp. 1631-1632
-
-
Monni, G.1
Ibba, R.M.2
Zoppi, M.A.3
-
66
-
-
10644241716
-
Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies
-
Spencer K, Aitken D. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies. Ultrasound Obstet Gynecol 2004, 24:735-739.
-
(2004)
Ultrasound Obstet Gynecol
, vol.24
, pp. 735-739
-
-
Spencer, K.1
Aitken, D.2
|